USPTO serial 79268936
REIWA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 25, 2020
- Examiner
- GUROK, GALINA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with REIWA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,275
Owner
TV TRADE PROMOTION PHARMACEUTICAL AND INVESTMENT COMPANY LIMITED
Ho Chi Minh City, VN
Other trademarks owned by TV TRADE PROMOTION PHARMACEUTICAL AND INVESTMENT COMPANY LIMITED
TV TRADE PROMOTION PHARMACEUTICAL AND INVESTMENT COMPANY LIMITED
Ho Chi Minh City, VN
Other trademarks owned by TV TRADE PROMOTION PHARMACEUTICAL AND INVESTMENT COMPANY LIMITED
TV TRADE PROMOTION PHARMACEUTICAL AND INVESTMENT COMPANY LIMITED
Ho Chi Minh City, VN
Other trademarks owned by TV TRADE PROMOTION PHARMACEUTICAL AND INVESTMENT COMPANY LIMITED
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer Sheehan Anderson
Jennifer Sheehan Anderson Bridge Intellectual Property Services143 CadyCenter, Suite 209Northville, MI 48167UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Food for babies; medicines for human purposes, namely, anesthetics, muscle relaxants, analgesics, antipyretic preparations, anti-inflammatories, pharmaceutical preparations for treatment of gout and bone and joint diseases, antiallergic medicines, injectable pharmaceuticals for treatment of anaphylactic reactions, antidotes, anti-epileptic pharmaceutical preparations, anti-parasitics, antibacterial pharmaceuticals, preparations used for treatment of migraine, pharmaceutical preparations and substances for the treatment of immune system related diseases and disorders, pharmaceutical preparations for use in urology, cardiovascular agents for medical purposes, dermatologicals, diagnostic agents, preparations and substances for medical purposes, disinfectants and antiseptics, diuretics, medicines for the treatment of gastrointestinal diseases, hormonal preparations, pharmaceutical preparations and substances for the treatment of endocrine diseases and disorders, antitoxic sera, cholinesterase inhibitors, ophthalmological preparations, otorhinolaryngological preparations, oxytocics, pharmaceutical solutions used in dialysis and blood purification, pharmaceutical preparations acting on the central and peripheral nervous systems, pharmaceutical products for treating respiratory diseases, electrolytes for medical use, mineral and vitamin supplements; medicines for veterinary purposes, namely, antibacterial pharmaceuticals, hormonal preparations, vitamins and dietary food supplements for animals, antiseptics, analgesics, antipyretics preparations, medicinal herbal preparations, insecticides, fungicides, enzyme preparations for veterinary purposes; nutritional supplements; pharmaceuticals, namely anesthetics, muscle relaxants, analgesics, antipyretic preparations, anti-inflammatories, pharmaceutical preparations for treatment of gout and bone and joint diseases, antiallergic medicines, injectable pharmaceuticals for treatment of anaphylactic reactions, antidotes, anti-epileptic pharmaceutical preparations, anti-parasitics, antibacterial pharmaceuticals, preparations used for treatment of migraine, pharmaceutical preparations and substances for the treatment of immune system related diseases and disorders, pharmaceutical preparations for use in urology, cardiovascular agents for medical purposes, dermatologicals, diagnostic agents, preparations and substances for medical purposes, disinfectants and antiseptics, diuretics, medicines for the treatment of gastrointestinal diseases, hormonal preparations, pharmaceutical preparations and substances for the treatment of endocrine diseases and disorders, antitoxic sera, cholinesterase inhibitors, ophthalmological preparations, otorhinolaryngological preparations, oxytocics, pharmaceutical solutions used in dialysis and blood purification, pharmaceutical preparations acting on the central and peripheral nervous systems, pharmaceutical products for treating respiratory diseases, electrolytes for medical use, mineral and vitamin supplements, antibacterial pharmaceuticals, vitamins and dietary food supplements for animals, antiseptics, anesthetics, analgesics, antipyretics preparations, medicinal herbal preparations, insecticides, fungicides, enzyme preparations for medical purposes; powdered milk for babies | ACTIVE | — |
| 010 | Analyzers for bacterial identification for medical purposes; dental apparatus, electric, namely, dental drills, burrs, excavators, picks, organoleptic diagnostic testing apparatus for dental use, medical radiation apparatus, radiation therapy devices, X-ray diagnostic apparatus, X-ray CT scanners, radiotherapy apparatus, laser scalpels for medical use, X-ray apparatus for dental imaging; diagnostic apparatus for medical purposes, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing, ultrasonic medical diagnostic apparatus, ultrasonic therapy machines and apparatus, X-ray CT scanners, patient monitoring sensors and alarms, endoscopic equipment for medical purposes, medical apparatus, namely, respiratory equipment and monitors therefor, surgical devices and instruments, medical apparatus and instruments for use in positive emission tomography (PET) imaging used to monitor brain, heart and metabolic functions, electrocardiographs, magnetic resonance imaging apparatus for medical purposes, medical apparatus for intravenous administration of fluids, namely, fluid warmers, medical equipment, namely, computed tomography (CT) apparatus, medical apparatus and instruments for monitoring oximeter, gas analysis, vital signs, blood properties and respiratory events, hematology analyzers for medical diagnostic uses, breath gas analyzers for medical diagnostics, analyzers for bacterial and viral identification for medical purposes, blood glucose meters; lamps for medical purposes, namely, surgical lamps, medical, surgical and dental operating lamps, medical examination lamps; medical apparatus and instruments, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing, wound care kits comprised of wound irrigation apparatus, ostomy flanges used with pouching systems, loupes for medical purposes, namely, magnifying glasses that fit on the user's face in the manner of eyeglasses, microscopes for surgical operations, lasers for the cosmetic treatment of the face and skin, electrocardiographs, ultrasonic medical diagnostic apparatus, ultrasonic therapy machines and apparatus, X-ray CT scanners, magnetic resonance imaging apparatus for medical purposes, patient monitoring sensors and alarms, endoscopic equipment for medical purposes, medical apparatus, namely, respiratory equipment and monitors therefor, surgical devices and instruments, ultraviolet lamps for medical purposes, medical devices, namely, radiation devices in the nature of ultraviolet, visible, or infra-red light boxes for counteracting the effects of viruses, bacteria and pathogens in the blood and blood components, ultraviolet radiator units for therapeutic purposes, disposable syringes, infusion and injection devices for administering drugs, needles for medical use, medical needles and introducers, lancets, medical lancing devices, cannulae, catheters, intravenous feeding tubes, enteral feeding tubes, apparatus for taking blood samples, dental drills, dental burrs, dental excavators, dental picks, lasers for medical use, medical apparatus for intravenous administration of fluids, namely, fluid warmers, electronic instruments and appliances in the nature of medical imaging apparatus used in medical, surgical or dental sciences, defibrillators, electric scalpels for surgical purposes, laser scalpels for medical use, anesthesia machines, medical ventilators, incubators for medical purposes, dialysis machines, cryosurgical apparatus for use in performing ablative surgery, cardiopulmonary bypass machine being medical apparatus for treating cardiovascular disease, blood pump system for use in artificial liver support, hemodialysis apparatus, dialysis machines, orthopaedic splints, medical boots for foot fractures and broken ankles, artificial teeth, artificial joints, artificial cardiac valves, artificial vascular grafts, ortheses and artificial limbs, artificial cartilage, artificial hip implants, cochlear implants made of artificial materials, dental implants made of artificial materials, artificial eyes, implants consisting of artificial materials, artificial breast implants, artificial urethral sphincters, artificial jaws, artificial skin for surgical purposes, medical, surgical and orthopaedic implants made of artificial materials, hearing aids, cardiac pacemakers, medical stents, vascular closure devices, medical equipment, namely, computed tomography (CT) apparatus, organoleptic diagnostic testing apparatus for dental use, X-ray apparatus for dental imaging, X-ray apparatus for medical purposes, X-ray diagnostic apparatus, medical radiation apparatus, radiation therapy devices, radiotherapy apparatus, laser scalpels for medical use, medical apparatus and instruments for use in positive emission tomography (PET) imaging used to monitor brain, heart and metabolic functions, thermometers for medical purposes, infrared thermometers for medical purposes, medical apparatus and instruments for monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events, hematology analyzers for medical diagnostic uses, breath gas analyzers for medical diagnostics, analyzers for bacterial and viral identification for medical purposes, blood glucose meters, dentists' chairs and parts thereof, furniture especially made for medical purposes, operating tables, hospital beds for burn patients, medical procedure chairs, commode chairs; veterinary apparatus and instruments, namely, castrating apparatus, ultrasound apparatus for veterinary use, x-ray apparatus for veterinary use; containers especially made for medical waste | ACTIVE | — |
| 042 | Architectural services; biological research; cloud computing, namely, providing virtual computer systems and virtual computer environments through cloud computing; cosmetics research; scientific laboratory services; quality control for others; scientific research; technological consultancy in the field of pharmaceutical industry | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TV TRADE PROMOTION PHARMACEUTICAL AND INVESTMENT COMPANY LIMITED
- Other trademarks owned by TV TRADE PROMOTION PHARMACEUTICAL AND INVESTMENT COMPANY LIMITED
- Other trademarks owned by TV TRADE PROMOTION PHARMACEUTICAL AND INVESTMENT COMPANY LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named REIWA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 25, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 15, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 15, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Feb 15, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 15, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 20, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 2, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 2, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 25, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 25, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 12, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 9, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 27, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 27, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 20, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 4, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 27, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 24, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 24, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 24, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 13, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 13, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 13, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 17, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 17, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 17, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 17, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 17, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 17, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 17, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 17, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 4, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 4, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 15, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 13, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 12, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 12, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 11, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 11, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 10, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |